Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 2, 2016HematologyOpen Access

Diffuse large B-cell lymphoma: R-CHOP failure—what to do?

View Full Paper
Ask AI
Bookmark
Share

Authors

Bertrand Coiffier
Bertrand CoiffierUniversité Claude Bernard Lyon 1CSClémentine SarkozyUniversité de Versailles Saint-Quentin-en-Yvelines

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Coiffier et al. (2016) studied this question.

synapsesocial.com/papers/69d8d117183921ebcaae3c2fhttps://doi.org/10.1182/asheducation-2016.1.366
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients2014 · 76 citations
  2. 2An RCOR1 loss–associated gene expression signature identifies a prognostically significant DLBCL subgroup2014 · 27 citations
  3. 3Brentuximab vedotin demonstrates objective responses in a phase 2 study of relapsed/refractory DLBCL with variable CD30 expression2015 · 303 citations
  4. 4Quantitative and qualitative analysis of metabolic response at interim positron emission tomography scan combined with International Prognostic Index is highly predictive of outcome in diffuse large B-cell lymphoma2013 · 73 citations
  5. 5Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review2015 · 169 citations